[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-deutsche-krebshilfe-krebs-therapiestudien-2026":3,"similar-deutsche-krebshilfe-krebs-therapiestudien-2026":29},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":9,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":10,"consortium":8,"first_seen":11,"last_updated":8,"update_note":8,"status":12,"stages":13,"call_frequency":14,"next_call_expected":8,"source_url":7,"created_at":15,"updated_at":16,"eligible_countries":17,"description":19,"seo_summary":20,"canonical_id":4,"links":21},"deutsche-krebshilfe-krebs-therapiestudien-2026","Krebs-Therapiestudien","Deutsche Krebshilfe","https:\u002F\u002Fwww.krebshilfe.de\u002Fforschen\u002Ffoerderung\u002Ffoerderprogramme\u002Fkrebstherapiestudien\u002F",null,"Rolling deadline — applications accepted at any time",false,"2026-07-26T00:00:00.000Z","open","2-stage: short application (Teil I) → full application (Teil II, by invitation only)","Continuous","2026-07-26T06:08:27.976Z","2026-07-26T07:10:25.852Z",[18],"DE","Funds non-commercial, investigator-initiated cancer therapy trials (Investigator Initiated Trials). Applicants submit a short-form Part I application; Part II is submitted only upon invitation from Deutsche Krebshilfe. Requires patient recruitment plan and sponsor declaration. Proposals must be submitted in German.","{\"summary\":\"Deutsche Krebshilfe's Krebs-Therapiestudien programme funds non-commercial, investigator-initiated cancer therapy trials (IITs) in Germany on a rolling basis. Researchers submit a short-form Part I application; successful proposals are invited to submit a full Part II application. All proposals must be submitted in German and include a patient recruitment plan and sponsor declaration.\",\"meta_description\":\"Deutsche Krebshilfe funds investigator-initiated cancer therapy trials in Germany, rolling deadline, applications in German, from Deutsche Krebshilfe.\",\"who_should_apply\":[\"Researchers designing non-commercial, investigator-initiated cancer therapy trials\",\"Applicants based at German institutions with capacity to recruit patients\",\"Clinical researchers with access to patient populations and trial infrastructure\",\"Teams prepared to submit applications in German and provide sponsor declarations\"],\"key_dates\":[\"Rolling deadline, applications accepted at any time\",\"Two-stage: Part I short application, then Part II full application by invitation only\"],\"tips\":[\"The Part I short application is a competitive filter, clarity and feasibility of the patient recruitment plan are decisive.\",\"Sponsor declaration must be in place before submission; confirm institutional support early to avoid delays in Part II.\"],\"faq\":[{\"q\":\"What type of research does Deutsche Krebshilfe fund under Krebs-Therapiestudien?\",\"a\":\"Non-commercial, investigator-initiated cancer therapy trials (IITs) designed and led by researchers, not pharmaceutical industry-sponsored studies.\"},{\"q\":\"How does the application process work for Krebs-Therapiestudien?\",\"a\":\"Applicants submit a short Part I application; Deutsche Krebshilfe invites successful proposals to submit a full Part II application.\"},{\"q\":\"Can I submit a Krebs-Therapiestudien application any time?\",\"a\":\"Yes, the programme has a rolling deadline and accepts applications at any time.\"},{\"q\":\"Do I need a sponsor declaration to apply?\",\"a\":\"Yes, a sponsor declaration is a mandatory requirement for Krebs-Therapiestudien applications.\"}],\"tags\":[\"cancer-therapy\",\"investigator-initiated-trials\",\"deutsche-krebshilfe\",\"germany\",\"clinical-trials\",\"non-commercial\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":22,"countryHubs":23,"domainHubs":27,"closingMonth":8,"hasRelated":10,"hasBrowseRelated":28},[],[24],{"slug":25,"demonym":26},"de","German researchers",[],true,{"grants":30},[31,34,37,40,43],{"id":32,"name":33,"funder":6,"deadline":8,"budget":8},"deutsche-krebshilfe-mildred-scheel-postdoktorandenprogramm-2026","Mildred-Scheel-Postdoktorandenprogramm",{"id":35,"name":36,"funder":6,"deadline":8,"budget":8},"deutsche-krebshilfe-krebs-pr-vention-und-fr-herkennung-normalverfahren-2026","Krebs-Prävention und -Früherkennung – Normalverfahren\u002FEinzelförderung",{"id":38,"name":39,"funder":6,"deadline":8,"budget":8},"deutsche-krebshilfe-max-eder-nachwuchsgruppenprogramm-2026","Max-Eder-Nachwuchsgruppenprogramm",{"id":41,"name":42,"funder":6,"deadline":8,"budget":8},"deutsche-krebshilfe-mildred-scheel-professur-2026","Mildred-Scheel-Professur",{"id":44,"name":45,"funder":6,"deadline":8,"budget":8},"deutsche-krebshilfe-klinische-forschung-kliniknahe-grundlagenforschung-2026","Klinische Forschung & kliniknahe Grundlagenforschung"]